🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vitiligo is a long-term autoimmune condition that causes the skin to lose i...
Status
Recruiting
Location
Dermatology Trial Associates
Start Date
2025-11-03
Trial ID
NCT07108283
Treatments Being Tested
The main aim of this study is to show how well TAK-279 reduces the skin pla...
Status
Completed
Location
Saguaro Dermatology Associates, LLC - Probity - PPDS
Start Date
2023-11-06
Trial ID
NCT06088043
Treatments Being Tested
The main aim of this study is to find out how the body processes 1 dose of ...
Status
Completed
Location
University of Miami
Start Date
2023-09-22
Trial ID
NCT05976321
Treatments Being Tested
The main aim of this study is to find out how more than one dose of TAK-279...
Status
Completed
Location
Celerion
Start Date
2024-04-29
Trial ID
NCT06258265
Treatments Being Tested
The main aim of this study is to see how well the medicine zasocitinib work...
Status
Recruiting
Location
Exalt Clinical Research
Start Date
2025-12-04
Trial ID
NCT07250802
Treatments Being Tested
The main aim of this study is to find out how the body of a healthy Chinese...
Status
Completed
Location
Huashan Hospital Fudan University
Start Date
2024-06-24
Trial ID
NCT06111547
The main aim of this study is to learn if TAK-279 reduces bowel inflammatio...
Status
Active Not Recruiting
Location
GastroIntestinal BioSciences
Start Date
2024-03-29
Trial ID
NCT06254950
The main aim of this study is to find out how zasocitinib (TAK-279) interac...
Status
Completed
Location
Celerion
Start Date
2025-01-23
Trial ID
NCT06793943
Treatments Being Tested
The main aim of this study is to check the side effects of TAK-279 and how ...
Status
Active Not Recruiting
Location
Total Dermatology
Start Date
2024-09-04
Trial ID
NCT06550076
Treatments Being Tested
The main aim of this study is to check if TAK-279 improves symptoms of With...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2024-03-19
Trial ID
NCT06323356
Treatments Being Tested